First Page | Document Content | |
---|---|---|
![]() Date: 2013-07-21 06:10:18Pharmaceutical industry Medicine Multiple sclerosis Cladribine Purines European Medicines Agency Glatiramer acetate Clinical trial Committee for Medicinal Products for Human Use Pharmacology Health Clinical research | Add to Reading List |
![]() | November 12, 2014 Dear Colleagues, Please find below details of a high priority clinical study just opened to patient accrual at the Northwestern Medicine Developmental Therapeutics Institute (NMDTI). A Pivotal MulticentDocID: 1aF51 - View Document |
![]() | [PRODUCT NAME] [Dose Form]DocID: 14SOe - View Document |
![]() | Cladribine Chemotherapy Information: Cladribine Medication information leaflet forDocID: 11tvl - View Document |
![]() | 2-Chloro-2’-deoxyadenosine 2-CdA, Cladribine 9-(2’-Deoxy-β-D-ribofuranosyl)-2-chloro-adenine Cat. No.DocID: Q5rN - View Document |
![]() | PDF DocumentDocID: yrY9 - View Document |